Form D · Biotechnology

Entera Bio Ltd.

Jerusalem, L3 · CIK 0001638097

Offering snapshot reported Aug 12, 2026 · SEC filing

Reported sold
$275M
Offering amount: $275M
Investors reported
53
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 28, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 12, 2026Initial$274,999,976No comparison53SEC filing
Jan 2, 2024Initial$6,610,604No comparison52SEC filing
Dec 26, 2019Initial$13,533,000No comparison52SEC filing
Oct 19, 2017Initial$2,022,944No comparison30SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$13.7M
Finders' fees
$0
Form D file number
021-593899
Offering amount (rounded) reflects an aggregate of 122,961,215 Ordinary Shares and 11,842,695 Pre-Funded Warrants
Pre-Funded Warrants, and underlying Ordinary Shares

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Leerink Partners LLCNone
Evercore Group L.L.C.000042405
Guggenheim Securities, LLC000040638
Cantor Fitzgerald & Co.000000134
LifeSci Capital, LLC000168404
Canaccord Genuity LLC000001020

Source: Form D, filed Aug 12, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Ben Ami Director
Luke M. Beshar Director
Zeev Bronfeld Director
Faith Charles Director
Chaim Davis Director
Sean Ellis Director
Hillel Galitzer Executive
Roger Garceau Director
Geno J. Germano Director
Adam Gridley Director, Executive
Gerald Lieberman Director
Yonatan Malca Director
Ron Mayron Director
Gerald Ostrov Director
Gerald M. Ostrov Director
Steven D. Rubin Director
Arthur Santora Executive
Phillip Schwartz Director, Executive
Haya Taitel Director
Miranda Toledano Director, Executive
Dana Yaacov Executive
Dana Yaacov Garbeli Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Kiryat Hadassah Minray Building Fifth Floor
Jerusalem, L3, 9112002
Phone: 972-2-532-7151